“…The central role of PA in the pathophysiology of anthrax makes it an excellent therapeutic target. Reports have indicated that vaccination with the PA-based human anthrax vaccine (19) or purified PA (20) results in the development of a protective immune response. Protective passive immunization with polyclonal antibodies against toxin proteins, particularly PA, has been demonstrated from challenge with B. anthracis spores (21,22).…”